We focus where commercialization risk is highest and résumé pedigree is least predictive — small to mid-sized Life Sciences companies under 1,000 employees, typically post-seed through commercial scale-up.
Within MedTech and Life Sciences we operate across the sectors where commercialization complexity rewards a structured hiring approach.
Structural heart, electrophysiology, vascular intervention, peripheral devices, and rhythm management.
Reconstruction, trauma, spine, extremities, sports medicine, and digital surgical platforms.
Minimally invasive platforms, surgical robotics, energy devices, and capital equipment commercialization.
Molecular diagnostics, point-of-care, imaging hardware, AI-enabled diagnostics, and lab services.
Software as a medical device, remote monitoring, connected therapeutics, and clinical decision support.
Research instruments, bioprocessing, clinical lab automation, and translational research platforms.
From first commercial hire through full GTM build-out, we run engagements at every level of commercial leadership in growth-stage environments.
Full P&L ownership, commercial strategy, market access, and revenue accountability.
Regional VPs, national sales directors, and capital equipment sales leadership.
Commercialization marketing, product marketing, downstream marketing, and brand strategy.
Health economics, payer strategy, coding & coverage, and reimbursement build-out.
Strategy calls are sector-calibrated. We'll discuss the role inside the context of your specific commercialization environment — not a generic search conversation.